Analysts Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Price Target at $17.71

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Free Report) have been assigned a consensus rating of “Reduce” from the sixteen brokerages that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $17.71.

A number of brokerages recently commented on WBA. JPMorgan Chase & Co. decreased their price target on Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating for the company in a research report on Monday, July 1st. Truist Financial decreased their price target on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Barclays decreased their target price on Walgreens Boots Alliance from $21.00 to $19.00 and set an “underweight” rating for the company in a research report on Monday, June 24th. Evercore ISI decreased their target price on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a research report on Friday, June 28th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd.

Check Out Our Latest Analysis on WBA

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 17.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Walgreens Boots Alliance

Large investors have recently added to or reduced their stakes in the business. Highlander Capital Management LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter valued at $26,000. Pineridge Advisors LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth about $26,000. Venturi Wealth Management LLC lifted its stake in Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the last quarter. Rocky Mountain Advisers LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth about $30,000. Finally, Quest Partners LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth about $30,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $10.79 on Friday. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $9.31 billion, a price-to-earnings ratio of -1.60, a PEG ratio of 0.78 and a beta of 0.72. The stock has a 50 day moving average of $15.56 and a 200 day moving average of $19.43. Walgreens Boots Alliance has a 12 month low of $10.69 and a 12 month high of $31.32.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The business had revenue of $36.40 billion for the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business’s revenue was up 2.8% compared to the same quarter last year. During the same period in the previous year, the business posted $1.00 earnings per share. As a group, sell-side analysts forecast that Walgreens Boots Alliance will post 2.87 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 9.27%. The ex-dividend date of this dividend was Monday, May 20th. Walgreens Boots Alliance’s payout ratio is currently -14.84%.

Walgreens Boots Alliance Company Profile

(Get Free Report

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.